FDA Rejects Teva Pharmaceutical Industries Limited Petition Against Generic Copaxone To Be Made By Momenta Pharmaceuticals, Inc. And Mylan Inc.

Wall Street Journal -- NEW YORK (Dow Jones)--The Food and Drug Administration has again denied Teva Pharmaceutical Industries Ltd.'s (TEVA) citizen’s petition asking the agency to block approval of a generic version of its Copaxone multiple sclerosis treatment.